Sapin A - Search Results

1

Stealth nanoparticles coated with heparin as peptide or protein carriers.

Socha M, Bartecki P, Passirani C, Sapin A, Damgé C, Lecompte T, Barré J, El Ghazouani F, Maincent P. Socha M, et al. Among authors: sapin a. J Drug Target. 2009 Sep;17(8):575-85. doi: 10.1080/10611860903112909. J Drug Target. 2009. PMID: 19694611

2

Influence of polymers ratio on insulin-loaded nanoparticles based on poly-epsilon-caprolactone and Eudragit RS for oral administration.

Socha M, Sapin A, Damgé C, Maincent P. Socha M, et al. Among authors: sapin a. Drug Deliv. 2009 Nov;16(8):430-6. doi: 10.3109/10717540903223442. Drug Deliv. 2009. PMID: 19839787 Free article.

3

Pellets for oral administration of low-molecular-weight heparin.

Scala-Bertola J, Gajdziok J, Rabisková M, Bonneaux F, Lecompte T, Sapin A, Maincent P. Scala-Bertola J, et al. Among authors: sapin a. Drug Dev Ind Pharm. 2009 Dec;35(12):1503-10. doi: 10.3109/03639040903037207. Drug Dev Ind Pharm. 2009. PMID: 19929210

4

Oral administration of a microencapsulated low-molecular-weight heparin to rabbits: anti-Xa and anti-IIa profiles.

Javot L, Sapin A, Scala-Bertola J, Vigneron C, Lecompte T, Maincent P. Javot L, et al. Among authors: sapin a. Thromb Haemost. 2010 Jun;103(6):1254-67. doi: 10.1160/TH09-10-0684. Epub 2010 Apr 13. Thromb Haemost. 2010. PMID: 20390227

5

Evaluation of subcutaneous forms in the improvement of pharmacokinetic profile of warfarin.

Scala-Bertola J, Javot L, Camargo JA, Bonneaux F, Lecompte T, Maincent P, Sapin A. Scala-Bertola J, et al. Among authors: sapin a. Int J Pharm. 2012 Jul 15;431(1-2):33-8. doi: 10.1016/j.ijpharm.2012.03.053. Epub 2012 Apr 17. Int J Pharm. 2012. PMID: 22531852

6

Effect of the microencapsulation of nanoparticles on the reduction of burst release.

Hasan AS, Socha M, Lamprecht A, Ghazouani FE, Sapin A, Hoffman M, Maincent P, Ubrich N. Hasan AS, et al. Among authors: sapin a. Int J Pharm. 2007 Nov 1;344(1-2):53-61. doi: 10.1016/j.ijpharm.2007.05.066. Epub 2007 Jun 13. Int J Pharm. 2007. PMID: 17643878

7

Composite microparticles with in vivo reduction of the burst release effect.

Sheikh Hassan A, Sapin A, Lamprecht A, Emond E, El Ghazouani F, Maincent P. Sheikh Hassan A, et al. Among authors: sapin a. Eur J Pharm Biopharm. 2009 Nov;73(3):337-44. doi: 10.1016/j.ejpb.2009.07.009. Epub 2009 Aug 3. Eur J Pharm Biopharm. 2009. PMID: 19651210

8

Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.

Gargouri M, Sapin A, Arıca-Yegin B, Merlin JL, Becuwe P, Maincent P. Gargouri M, et al. Among authors: sapin a. Int J Pharm. 2011 Jan 17;403(1-2):276-84. doi: 10.1016/j.ijpharm.2010.10.040. Epub 2010 Oct 29. Int J Pharm. 2011. PMID: 21044878

9

Injectable PLA-based in situ forming implants for controlled release of Ivermectin a BCS Class II drug: solvent selection based on physico-chemical characterization.

Camargo JA, Sapin A, Nouvel C, Daloz D, Leonard M, Bonneaux F, Six JL, Maincent P. Camargo JA, et al. Among authors: sapin a. Drug Dev Ind Pharm. 2013 Jan;39(1):146-55. doi: 10.3109/03639045.2012.660952. Epub 2012 Mar 8. Drug Dev Ind Pharm. 2013. PMID: 22397675

10

Ivermectin-loaded microparticles for parenteral sustained release: in vitro characterization and effect of some formulation variables.

Camargo JA, Sapin A, Daloz D, Maincent P. Camargo JA, et al. Among authors: sapin a. J Microencapsul. 2010;27(7):609-17. doi: 10.3109/02652048.2010.501397. J Microencapsul. 2010. PMID: 20695833

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters